| answer text |
<p>The National Health Service will remain the primary provider for cervical cytology
screening in England and cervical screening remains part of the General Medical Services
contract.</p><p> </p><p>In November 2015, the UK National Screening Committee recommended
that human papillomavirus (HPV) screening should replace the currently used liquid
based cytology test as the primary screening for cervical disease.</p><p> </p><p>Following
a review of its delivery strategy, NHS England commenced a one-stage procurement process
to reconfigure provider laboratories to support the roll-out of HPV primary screening
into the NHS Cervical Cancer Screening Programme in England. HPV primary screening
is due to be rolled out in 2019.</p><p> </p><p>Once full implementation is achieved,
all samples will be tested for HPV which causes more than 99% of cervical cancers.
This could prevent around 600 cancers a year.</p>
|
 |
